Immunofluorescence assays revealed that KAT6A formed more biomolecular condensates in PARPi‐resistant ovarian cancer than in parental cells (Figure 2A,B; Video S1, Supporting Information). The gene discussed is KAT6A; the disease is ovarian cancer.